MEDICINOVA, INC. Interest Expense
MEDICINOVA, INC. (MNOV) reported Interest Expense of $298 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2018-02-13
- MEDICINOVA, INC. interest expense for the quarter ending 2015-03-31 was $140.00, a 13.82% increase year-over-year.
- MEDICINOVA, INC. interest expense for the quarter ending 2014-12-31 was $151.00.
- MEDICINOVA, INC. interest expense for the quarter ending 2014-09-30 was $173.00.
- MEDICINOVA, INC. interest expense for the quarter ending 2014-06-30 was $181.00.
- MEDICINOVA, INC. interest expense for fiscal 2017 was $298.00, a 34.36% decline from fiscal 2016.
- MEDICINOVA, INC. interest expense for fiscal 2016 was $454.00, a 11.67% decline from fiscal 2015.
- MEDICINOVA, INC. interest expense for fiscal 2015 was $514.00, a 18.15% decline from fiscal 2014.
- MEDICINOVA, INC. interest expense for fiscal 2014 was $628.00.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 129 month | Interest Expense 132 month | Interest Expense 135 month | Interest Expense 138 month | Interest Expense 141 month | Interest Expense 144 month | Interest Expense 147 month | Interest Expense 150 month | Interest Expense 153 month | Interest Expense 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $298.00 10-K · filed 2018-02-13 | ||||||||||||||||
| 2016-12-31 | $454.00 10-K · filed 2018-02-13 | ||||||||||||||||
| 2015-12-31 | $514.00 10-K · filed 2018-02-13 | ||||||||||||||||
| 2015-03-31 | $140.00 10-Q · filed 2015-05-11 | $291.00 derived: sum of 2 quarters · filed 2017-02-14 | $464.00 derived: sum of 3 quarters · filed 2017-02-14 | $645.00 derived: sum of 4 quarters · filed 2017-02-14 | |||||||||||||
| 2014-12-31 | $151.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $324.00 derived: sum of 2 quarters · filed 2017-02-14 | $505.00 derived: sum of 3 quarters · filed 2017-02-14 | $628.00 10-K · filed 2017-02-14 | |||||||||||||
| 2014-09-30 | $173.00 10-Q · filed 2014-11-13 | $354.00 derived: sum of 2 quarters · filed 2014-11-13 | $477.00 10-Q · filed 2014-11-13 | ||||||||||||||
| 2014-06-30 | $181.00 10-Q · filed 2014-08-13 | $304.00 10-Q · filed 2014-08-13 | |||||||||||||||
| 2014-03-31 | $123.00 10-Q · filed 2015-05-11 | ||||||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 derived: sum of 3 quarters · filed 2013-11-07 | $3.61M 10-Q · filed 2013-11-07 | |||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $0.00 derived: sum of 2 quarters · filed 2013-08-08 | $3.61M 10-Q · filed 2013-08-08 | ||||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $3.61M 10-Q · filed 2013-05-08 | |||||||||||||||
| 2012-12-31 | $3.61M 10-K · filed 2013-03-28 | ||||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | -$1.00 derived: sum of 4 quarters · filed 2013-03-28 | $3.61M 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 141 month − 10-Q 138 month · filed 2012-08-09 | $0.00 derived: sum of 2 quarters · filed 2012-08-09 | -$1.00 derived: sum of 3 quarters · filed 2013-03-28 | -$1.04K derived: sum of 4 quarters · filed 2013-03-28 | $3.61M 10-Q · filed 2012-08-09 | ||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 138 month − 10-K 135 month · filed 2012-05-10 | -$1.00 derived: sum of 2 quarters · filed 2013-03-28 | -$1.04K derived: sum of 3 quarters · filed 2013-03-28 | $942.71K derived: sum of 4 quarters · filed 2013-03-28 | $3.61M 10-Q · filed 2012-05-10 | ||||||||||||
| 2011-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$1.04K derived: sum of 2 quarters · filed 2013-03-28 | $942.71K derived: sum of 3 quarters · filed 2013-03-28 | $1.60M 10-K · filed 2013-03-28 | $3.61M 10-K · filed 2012-03-29 | ||||||||||||
| 2011-09-30 | -$1.04K 10-Q · filed 2012-11-08 | $0.00 10-Q · filed 2011-11-14 | $942.71K derived: sum of 2 quarters · filed 2012-11-08 | $1.60M 10-Q · filed 2012-11-08 | $1.10M 10-Q · filed 2011-11-14 | $2.25M derived: sum of 4 quarters · filed 2012-11-08 | $3.11M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $943.75K 10-Q · filed 2012-08-09 | $450.00K 10-Q · filed 2011-08-15 | $1.60M 10-Q · filed 2012-08-09 | $1.10M 10-Q · filed 2011-08-15 | $2.25M derived: sum of 3 quarters · filed 2012-08-09 | $2.91M derived: sum of 4 quarters · filed 2012-08-09 | $3.11M 10-Q · filed 2011-08-15 | ||||||||||
| 2011-03-31 | $652.39K 10-Q · filed 2012-05-10 | $1.31M derived: sum of 2 quarters · filed 2012-05-10 | $1.97M derived: sum of 3 quarters · filed 2012-05-10 | $2.38M derived: sum of 4 quarters · filed 2012-05-10 | |||||||||||||
| 2010-12-31 | $658.63K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $1.32M derived: sum of 2 quarters · filed 2012-03-29 | $1.72M derived: sum of 3 quarters · filed 2012-03-29 | $1.77M 10-K · filed 2012-03-29 | |||||||||||||
| 2010-09-30 | $659.28K 10-Q · filed 2011-11-14 | $1.07M derived: sum of 2 quarters · filed 2011-11-14 | $1.11M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $406.27K 10-Q · filed 2011-08-15 | $450.44K 10-Q · filed 2011-08-15 | |||||||||||||||
| 2009-12-31 | $242.37K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |